We've found
881 Irritable Bowel Syndrome (IBS)
clinical trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Using Virtual Reality for Patients With Gastrointestinal Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Characterized by Constipation Clinical Trial
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
The Healthy Life Choices Project in HIV-Positive Patients
Status: Enrolling,
Phase
I
Updated: 12/8/2005
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology
Status: Enrolling
Updated: 5/15/2014
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal Clinical Trial
Efficacy of Open Label Placebo in Children With FGIDs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Other Clinical Trial
Vitamin D Supplementation in IBS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
Cytokines and Genes in Therapeutic Response in Crohn's Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome (IBS) Clinical Trial
Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Status: Enrolling
Updated: 8/1/2017
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology, Orthopedics / Podiatry Clinical Trial
Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
We've found
881 Irritable Bowel Syndrome (IBS)
clinical trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Endocrinology, Gastroenterology, Hematology Clinical Trial
Updated: 12/31/1969
S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Using Virtual Reality for Patients With Gastrointestinal Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Characterized by Constipation Clinical Trial
Updated: 12/31/1969
Low FODMAP Plus PEG 3350 for the Treatment of Patients With Irritable Bowel Syndrome-Constipation
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Evaluate the Efficacy and Safety of Vibegron Administered Orally for 12 Weeks to Women With Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 12/8/2005
The Healthy Life Choices Project in HIV-Positive Patients
Status: Enrolling,
Phase
I
Updated: 12/8/2005
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/7/2008
A Study of the Safety and Effectiveness of DDP733 in Treating IBS With Constipation in Females
Status: Enrolling,
Phase
II, III
Updated: 4/7/2008
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Updated: 12/31/1969
A Multicenter National Prospective Study of Pregnancy and Neonatal Outcomes in Women With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Disease Clinical Trial
Updated: 12/31/1969
Multi-Center African-American Inflammatory Bowel Disease Study (MAAIS)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 5/15/2014
Temple Registry for the Investigation of African American Gastrointestinal Disease Epidemiology
Status: Enrolling
Updated: 5/15/2014
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 12/13/2013
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 12/13/2013
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 12/13/2013
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 12/13/2013
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Diarrhea Predominant Irritable Bowel Syndrome Clinical Trial
Updated: 12/13/2013
A Phase 2 Pilot Study to Assess ASP7147 in Patients With Diarrhea Predominant Irritable Bowel Syndrome (IBS-D)
Status: Enrolling,
Phase
II
Updated: 12/13/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/25/2013
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/25/2013
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/25/2013
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/25/2013
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 4/25/2013
A Multi-Center Trial to Determine the Safety and Efficacy of LX1033 in Subjects With Diarrhea-Predominant Irritable Bowel Syndrome
Status: Enrolling
Updated: 4/25/2013
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 1/3/2017
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 1/3/2017
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases Clinical Trial
Updated: 1/3/2017
Study to Determine Risk Factors for Post-operative Infection in Inflammatory Bowel Disease
Status: Enrolling
Updated: 1/3/2017
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Updated: 12/31/1969
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Rheumatology Clinical Trial
Updated: 12/31/1969
Trial Evaluating Chemoprophylaxis Against Travelers' Diarrhea - Prevent TD
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 7/6/2016
Evaluation of the Efficacy and Safety of Lubiprostone in Adults With Mixed or Unsubtyped Irritable Bowel Syndrome
Status: Enrolling,
Phase
II
Updated: 7/6/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 12/31/1969
A Safety and Efficacy Study of a Range of Linaclotide Doses Administered Orally to Children Ages 7-17 Years, With Irritable Bowel Syndrome With Constipation
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal Clinical Trial
Updated: 12/31/1969
Efficacy of Open Label Placebo in Children With FGIDs
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Irritable Bowel Syndrome With Constipation Clinical Trial
Updated: 1/12/2016
Trial of Linaclotide in Patients With Irritable Bowel Syndrome With Constipation (IBS-C)
Status: Enrolling,
Phase
II
Updated: 1/12/2016
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Improving the Quality of Care for Adults With Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Immunology / Infectious Diseases, Oncology, Other Clinical Trial
Updated: 12/31/1969
Neomycin and Metronidazole Hydrochloride With or Without Polyethylene Glycol in Reducing Infection in Patients Undergoing Elective Colorectal Surgery
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Musculoskeletal, Other Clinical Trial
Updated: 12/31/1969
Vitamin D Supplementation in IBS
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Inflammatory Bowel Diseases Clinical Trial
Updated: 12/31/1969
Cytokines and Genes in Therapeutic Response in Crohn's Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
Personalized Research on Diet in Ulcerative Colitis and Crohn's Disease
Status: Enrolling
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology Clinical Trial
Updated: 12/31/1969
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Inflammatory Bowel Disease
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome (IBS) Clinical Trial
Updated: 8/1/2017
Microbiome Fructan Metabolism and Symptoms in Childhood IBS
Status: Enrolling
Updated: 8/1/2017
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Irritable Bowel Syndrome Clinical Trial
Updated: 12/31/1969
Study to Explore the Therapeutic Effect of Eluxadoline in Treating Irritable Bowel Syndrome With Diarrhea in Children.
Status: Enrolling,
Phase
II
Updated: 12/31/1969
Click here to add this to my saved trials
Gastroenterology, Hematology, Orthopedics / Podiatry Clinical Trial
Updated: 12/31/1969
Precision Diagnostics in Inflammatory Bowel Disease, Cellular Therapy and Transplantation (The PREDICT Trial)
Status: Enrolling,
Phase
Updated: 12/31/1969
Click here to add this to my saved trials